IMIrene Margreet Jacqueline Mathijssen

Irene Margreet Jacqueline Mathijssen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Irene Margreet Jacqueline Mathijssen has a total of 160 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-Term Speech Outcomes in Unilateral Cleft Lip and Palate: A Comparative Study of Early and Delayed Hard Palate Closure

    by V.L. van Roey, L. Hofman, P.A.J. van der Goes, H.G. Poldermans, S. J. Haverkamp, E.C. Paes, A.B. Mink van der Molen, I.M.J. Mathijssen, S.L. Versnel

    Background: Evidence on the comparative effectiveness of surgical protocols for cleft lip and palate remains limited, especially regarding long-term speech outcomes. Therefore, this study evaluates speech outcomes at 5, 12, and 22 years in patients with unilateral cleft lip and palate (UCLP) to guide protocol selection. Methods: This prospective cross-sectional study included 285 UCLP patients treated at 2 Dutch academic hospitals. Patients were assessed at 1 of 3 predefined ages (5, 12, or 22 y) during routine follow-up; only a minority were assessed at more than one time point. Four protocols with different timing for hard palate closure were compared: Late Delayed Hard Palate Closure Protocol (L-DHPCP), Early Delayed Hard Palate Closure Protocol (E-DHPCP), One-Stage Palatoplasty Protocol (OSPP), and Oslo Protocol (OP). Speech outcomes were assessed using the ICHOM standard set for cleft lip and palate, including clinical (Percent Consonant Correct, Velopharyngeal Competence) and patient-reported (Intelligibility in Context Scale, CLEFT questionnaire) outcome measures and compared using ordinal logistic regression. Results: At 5 years, OSPP showed the most favourable speech results, significantly outperforming L-DHPCP and E-DHPCP. At 12 years, OP exhibited the most favourable results, while differences between protocols diminished. By 22 years, no significant differences were observed between the available protocols (E-DHPCP and L-DHPCP), though speech errors persisted in some patients. Conclusion: Early hard palate closure protocols, particularly OSPP and OP, were associated with better short-term and intermediate speech outcomes compared with DHPCPs. While differences diminished by 22 years, early closure should be prioritised in nonsyndromic UCLP patients to prevent persistent speech errors and minimise the burden of speech-enhancing surgery and speech therapy.


  • Open Access

    The Development of a European Registry for Facial Dysostosis Syndromes: A Delphi-Guided Approach

    by Victor L. PhD van Roey, Saranda Ombashi, Irene M.J. Mathijssen, Åsa A. Msc Munkhammar, Pamela M. Bsc Åsten, Anouar Bouzariouh, Charlotte Célérier, Caroline Dana, Marieke van Dooren, Mariët Msc Faasse, et al.

    Facial dysostosis syndromes (FDS) are rare congenital conditions that significantly impact facial function and appearance. At the time of this writing, standardised monitoring protocols for FDS are lacking, hampering research, and evidence-based care. Thus, a comprehensive dataset was developed within the European Reference Network for Rare and Complex Craniofacial Anomalies (ERN CRANIO). Candidate data elements were identified through a systematic literature review (1985–2024) and supplemented with elements from existing ERN CRANIO datasets and expert panel suggestions. A Delphi survey was then conducted among 61 clinicians and 3 patient representatives to assess each element’s relevance and reliability using a 9-point Likert scale. A subsequent hybrid consensus meeting with the expert panel shaped the final dataset, ensuring comprehensive coverage, avoiding overlap, and determining the appropriate timing for data collection. Of 200 data elements that entered the Delphi voting, 98 were strongly recommended, 102 scored neutral, and none were strongly discouraged. Ultimately, 110 elements were included, organised into 2 levels: Level 1, comprising exclusively patient-reported and parent-reported outcome measures; and Level 2, encompassing patient characteristics, treatment information, clinical outcomes, and imaging/diagnostics. This newly developed dataset marks the first international registry for FDS, offering considerable potential for collaborative research, cross-centre comparisons, and substantial improvements in care for patients with FDS worldwide. Real-world implementation will be essential to evaluate its feasibility and guide further refinements.


  • Open Access

    Unveiling the Phenotypic Spectrum of Miller Syndrome: A Systematic Review

    by Victor L. Msc van Roey, Saranda Ombashi, Idilay Bsc Kaymaz, Marieke F. van Dooren, Anne Goverde, Eppo B. MD Wolvius, Irene M.J. Mathijssen, Sarah L. Versnel

    Miller syndrome is an extremely rare condition in the group of facial dysostosis syndromes. These syndromes have great phenotypic overlap and variability, even within families. To facilitate the differentiation of Miller syndrome from related facial dysostosis syndromes, such as Treacher Collins and Nager syndrome, this study aims to provide an overview of the phenotypic spectrum of the syndrome. A systematic literature search of Embase, MEDLINE/PubMed, Web of Science, and CINAHL was conducted until November 2024. Case reports and case series of patients with a clinical or genetic diagnosis of Miller syndrome in all languages were included. The quality of the included reports was assessed using the Joanna Briggs Institute critical appraisal tool and the Fichas de Lectura Critica 3.0 web application. In total, 44 cases of Miller syndrome were found, with only 18.2% having genetic confirmation. Craniofacial anomalies were prominent, including midface hypoplasia (72.7%) and micrognathia (75.0%), orofacial clefts (77.3%), eyelid anomalies (70.5%), and external ear anomalies (63.6%). Limb anomalies were present in all cases, primarily involving the hands (95.5%), forearms (52.3%), and feet (90.9%). Anomalies in other extracraniofacial tracts were also reported. Despite limitations, including limited genetic confirmation and reliance on literature, this study provides valuable insights into the phenotypic spectrum of Miller syndrome. Efforts for genetic confirmation, international collaboration, and comprehensive reporting are essential to advance research and care for rare conditions like Miller syndrome. Therefore, a detailed checklist for phenotypic evaluation in Miller syndrome cases is provided in this study.


  • Open Access

    Semi-automated three-dimensional analysis of maxillary anomalies in patients with Muenke syndrome, Saethre-Chotzen syndrome or TCF12-related craniosynostosis: A retrospective study

    by Tsun Man Choi, Robin Bruggink, Jan Willem Mathijs Hoekstra, Irene Margreet Jacqueline Mathijssen, Eppo Bonne Wolvius, Edwin Mattheus Ongkosuwito


  • Open Access

    What Matters to Patients With Nonsyndromic Craniosynostosis and Their Parents: A Qualitative Study Informing the Development of a Patient-Reported Outcome Measures Set

    by Pauline A.E. Tio, Coralie J. Bsc Wijnhoven, Elin Msc Weissbach, Jacoba Msc Kats, Jolanda M.E. Okkerse, Irene M.J. Mathijssen, Karolijn Dulfer

    The primary objective of this study was to identify important concepts that hold significance for both patients with nonsyndromic craniosynostosis and their parents regarding their craniosynostosis care. The findings from this study will guide the development of patient-reported outcome measures (PROM) sets tailored to specific craniosynostosis subtypes and age groups, which will be implemented in our treatment protocol. A qualitative methodology was used, and data were obtained through focus groups. A purposive sample of patients and parents of patients with nonsyndromic craniosynostosis was collected at Sophia Children’s Hospital Erasmus Medical Center. The focus groups were recorded, transcribed verbatim, and analyzed using thematic content analysis. Important domains in the preoperative and postoperative period were identified. In total, 34 participants were included in this study, of which 24 parents and 10 patients were divided over 12 focus groups. Based on our qualitative data, 4 top-level domains were considered to be of importance in patients with nonsyndromic craniosynostosis and their parents, including: emotional and social, cognitive, physical, and disease-specific functioning. Each top-level domain consisted of subdomains. Findings from this qualitative study reveal domains important to patients with nonsyndromic craniosynostosis and their parents with regard to their outcomes in craniosynostosis care. The comprehensive framework derived from this study serves as a guideline for developing a craniosynostosis-specific PROM set of relevance to our population.


  • Open Access

    Clinical Nasal Deviation Following Midface Advancement in Patients With Syndromic Craniosynostosis

    by Iris E. Cuperus, Parinaz Rostamzad, Simone E. Bernard, Sarah L. Versnel, Laura L. Veder, Irene M.J. MD Mathijssen

    Introduction: Nasal deviations have been observed in patients following midface surgery. Therefore, the purpose of this study was to evaluate the development of clinically visible nasal deviations following midface surgery and to assess the natural course of the nose over time. Methods: This retrospective study included all Apert and Crouzon patients who underwent midface surgery (Le Fort III (LF3), monobloc (MB), or facial bipartition (FB)). Clinical nasal deviation was assessed on preoperative, short-term postoperative (≤ 1 year), and long-term postoperative (> 1 year) 2D facial photographs by consensus of pediatric ENT surgeons and one craniofacial surgeon. Additionally, pre- and postoperative CT scans were reviewed when available. Results: Sixty-eight procedures were included (27 Apert, 41 Crouzon); 34 LF3, 31 MB, and 3 FB. The median age at surgery was 10.2 years. Twenty-five (37%) patients were found to have clinically worsening nasal asymmetry, of whom 4 (16%) had pre-existing deviation preoperatively. Seventeen patients with worsening deviation had long-term postoperative facial photographs available (median time 5.8 years), and in 9 (53%), the postoperative clinical nasal deviation appeared to improve spontaneously. We were unable to identify predictive factors for postoperative nasal deviation. Conclusion: In 16% of the patients, a clinically deviated nose was observed preoperatively. Nasal deviation worsened in 37% of the patients after midface surgery, but also spontaneously improved in 53% of these patients over the long-term. Since predicting the occurrence of nasal deviation and self-correction is difficult, the possibility of developing nasal deviation should be discussed with the patient and their parents.

  • Risk of Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, and Executive Function Impairment in Metopic Craniosynostosis

    by Pauline A. E. Tio, Jolanda M. E. Okkerse, Karolijn Dulfer, Irene M. J. Mathijssen

    An abstract is unavailable. This article is available as a PDF only.


  • Open Access

    Normative CLEFT-Q Data From the General Dutch Population

    by Philip A.J. Bsc van der Goes, Victor L. Msc Van Roey, Saranda Ombashi, Irene M.J. Mathijssen, Aebele B. Mink van der Molen, Sarah L. Versnel

    Patient-Reported Outcome Measures (PROMs), such as the CLEFT-Q, have become essential for outcomes in patients with CL/P. Normative values of the CLEFT-Q for non-CL/P peers have not yet been established. This study aims to establish normative values for the CLEFT-Q in the general Dutch population. Dutch nationals aged 16-24 years without CL/P were recruited through an online survey. Participants completed the CLEFT-Q, excluding the lip scar and eating and drinking scales. Data were weighted based on the Dutch Central Bureau of Statistics. Normative values were calculated as means and standard deviations, stratified by sex and education category. Tobit regression models were used to analyze associations between CLEFT-Q scores and demographic variables. In total, 870 participants responded, of which 160 were excluded due to potential craniofacial anomalies. Significant variations in CLEFT-Q scores based on sex were found, with females scoring lower than males. Level of education had a modest impact on CLEFT-Q scores, with lower education having lower scores on certain scales. Age marginally influenced CLEFT-Q scores, with younger participants scoring lower than older participants. Positive correlations were found between all CLEFT-Q scales. The strongest correlation was observed between the social and school functioning scales. This study provides the first set of normative values for the CLEFT-Q in the Dutch general population. Significant differences in CLEFT-Q scores based on sex, level of education and age were found. These normative values are useful for clinicians interpreting CLEFT-Q scores and help make informed decisions.


  • Open Access

    The Development of a European Multidisciplinary Cleft Lip and Palate Registry by the European Reference Network CRANIO: Experiences, Barriers, And Facilitators

    by Philip A.J. van der Goes, Saranda Ombashi, Victor van Roey, Malin Hakelius, Irene M.J. Mathijssen, Aebele B. Mink van der Molen, Sarah L. Versnel

    The European Reference Network for Rare Craniofacial Aanomalies and Ear-Nose-Throat disorders aims to improve care for patients with such afflictions, including cleft lip and palate (CL/P) across Europe. Cleft treatment remains varied throughout European centers, inhibiting meaningful comparison of treatment outcomes. To overcome these issues, a European-wide common CL/P dataset and registry was developed, facilitating standardized treatment endpoints and outcome measures for international comparison and benchmarking of CL/P centers. Questionnaires and semi-structured interviews were used to determine the set-up of the registry. Previous CL/P initiatives were analyzed to create an initial dataset, refined through consensus meetings. In total, 87 cleft specialists working in specialized CL/P centers from 16 European nations participated. Consensus on a common dataset was reached. A “Level 1” dataset, with mandatory clinical and patient-reported outcome measures, and “Level 2” dataset with additional outcome measures. Finally, 2 dashboards were developed for data dissemination. The development of the European CL/P common dataset and registry tackled challenges with resource disparities, variations in specialists within CL/P teams, regulatory differences in patient data usage, patient-reported outcome measures availability in European languages, and use of assessment tools. This study described the successful development of the European Reference Network for Rare Craniofacial Aanomalies and Ear-Nose-Throat disorders CL/P common dataset and registry. This achievement will help improve patient care and outcomes for patients with CL/P in Europe. Furthermore, this study provides useful information for initiatives with similar aims.